Friday, September 4, 2026

CANCER SURVIVORSHIP & RECOVERY PROGRAM

A Whole-Person Approach to Active Treatment, Recovery and Life After Cancer

By: Lennard M. Goetze, Ed.D - for the National Cancer Collective

From Treatment to Recovery. From Recovery to Living Well.

Finishing cancer treatment is an extraordinary milestone, but it is not necessarily the end of cancer care. For many people, it marks the beginning of an entirely different phase of health management. Cancer and its treatments can leave lasting effects on the cardiovascular system, muscles, bones, metabolism, cognition, sleep, emotional health, sexual health, nutrition, mobility and overall stamina. Survivors may leave active treatment cancer-free yet continue to experience fatigue, weakness, neuropathy, weight changes, lymphedema, anxiety, hormonal changes, cognitive difficulties and uncertainty about what they should be doing next.

The Cancer Survivorship & Recovery Program is envisioned as a comprehensive cancer wellness program built around two interconnected missions: helping people remain as strong, active and nutritionally supported as medically appropriate during cancer treatment, and helping survivors rebuild and protect their health following treatment.

The philosophy is simple: Cancer care should not end when treatment ends—and wellness should not have to wait until treatment is over.

TWO PATHWAYS. ONE CONTINUUM OF CARE.

PATHWAY I — STAYING ACTIVE DURING CANCER TREATMENT

Maintaining Strength, Movement and Quality of Life During Treatment

Historically, people undergoing cancer treatment were often encouraged primarily to rest. Rest remains important, but cancer rehabilitation increasingly recognizes that appropriately prescribed physical activity can play an important role in maintaining function and quality of life during treatment.

This pathway provides individualized, medically appropriate exercise and supportive wellness strategies for people undergoing chemotherapy, radiation, immunotherapy, hormonal therapy, surgery and other cancer treatments.

This is not conventional fitness training. It is cancer-informed exercise and wellness support, coordinated whenever appropriate with the patient's oncology and medical team. Programs may include aerobic conditioning, resistance exercise, flexibility, balance, mobility, breathing exercises, restorative movement and progressive strength training. Exercise recommendations should be modified according to treatment schedules, fatigue, blood counts, surgical restrictions, neuropathy, cardiovascular considerations, bone health and other clinical factors.

The objective is not athletic performance. The objective is preservation—preserving strength, mobility, independence, confidence and quality of life while the individual moves through treatment.

PATHWAY II — POST-TREATMENT CANCER RECOVERY

Rebuilding Health After Treatment

The second pathway begins when treatment ends—or whenever the clinical team determines that the individual is ready to transition toward longer-term recovery. Post-treatment cancer recovery is organized around a question many survivors eventually ask: “What can I do now to become healthy again?”

The answer should be more comprehensive than simply returning for surveillance scans. Post-treatment survivorship requires a personalized roadmap addressing the physical, nutritional, psychological and lifestyle consequences of cancer treatment while helping survivors reduce modifiable health risks and pursue the best quality of life possible.

The program therefore organizes survivorship around several interconnected areas of health and recovery.

1. EXERCISE ONCOLOGY & PHYSICAL RECONDITIONING

Every participant should begin with an appropriate assessment of strength, mobility, balance, cardiovascular capacity and functional limitations. A progressive exercise oncology program can then address deconditioning, muscle loss, reduced endurance, treatment-related fatigue and loss of confidence in physical activity.

Exercise programming may incorporate cardiovascular conditioning, resistance training, flexibility, mobility, balance and functional movement based upon the individual's condition and medical circumstances.

The goal is to move the survivor progressively from recovery to conditioning, conditioning to strength, and strength to sustainable lifelong activity.

2. CANCER-INFORMED NUTRITION

Nutrition after cancer should not be built around fear, miracle foods or restrictive trends.

Registered dietitians or appropriately credentialed nutrition professionals can help survivors develop sustainable eating patterns supporting adequate protein intake, healthy body composition, metabolic and cardiovascular health, bone health and overall nutritional adequacy.

Where appropriate, nutritional support can also address treatment-related appetite changes, gastrointestinal difficulties, swallowing problems, altered taste, unintended weight loss, weight gain and other challenges that may continue following treatment.

The objective is not simply to create a diet. It is to help survivors establish a sustainable nutritional foundation for recovery and long-term health.

3. RECURRENCE-RISK REDUCTION & PREVENTIVE HEALTH

No responsible survivorship program should promise to prevent cancer recurrence. It can, however, help survivors address modifiable health and lifestyle factors associated with better overall health and, for some cancers, improved outcomes.

This component emphasizes physical activity, healthy weight management where appropriate, tobacco avoidance, alcohol-risk education, nutrition, adherence to prescribed medications, recommended cancer surveillance and management of cardiovascular and metabolic risk.

The message should be empowering rather than frightening: We cannot control everything about cancer, but we can help survivors take greater control of the health they have today.

4. CARDIOVASCULAR & METABOLIC HEALTH

Cancer survivorship is increasingly connected to long-term cardiovascular and metabolic health.

Depending upon treatment history and individual risk, survivors may benefit from monitoring blood pressure, lipids, glucose, body composition, cardiovascular fitness and other clinically appropriate indicators.

This becomes particularly important for people exposed to potentially cardiotoxic therapies or treatments associated with hormonal and metabolic changes.

Survivorship therefore becomes an opportunity not only to monitor for cancer recurrence, but also to address the individual's whole-health risk profile.

5. STRENGTH, BONE HEALTH & MOBILITY

Cancer treatment can contribute to muscle loss, weakness, frailty and changes in bone health.

Resistance training, weight-bearing activity, balance work, mobility exercises and appropriate nutritional support can therefore become important components of long-term survivorship.

The objective is bigger than fitness. It is about maintaining the physical reserve necessary for independence, mobility, resilience and healthy aging.

6. LYMPHEDEMA, NEUROPATHY & PHYSICAL REHABILITATION

Some survivors continue living with consequences of surgery, chemotherapy or radiation long after treatment ends. Access to oncology rehabilitation may include physical therapy, occupational therapy, lymphedema assessment and management, neuropathy support, mobility rehabilitation, scar and tissue management and strategies for returning safely to normal activities.

Rather than asking survivors simply to adapt to these limitations, the program encourages appropriate evaluation and rehabilitation wherever improvement may be possible.

7. SLEEP, STRESS & EMOTIONAL RECOVERY

Cancer affects more than the tumor. Fear of recurrence, anxiety, depression, sleep disruption, altered identity and the psychological transition away from intensive medical care can profoundly affect survivorship.

Behavioral health, stress management, mindfulness, peer support and sleep-health strategies should therefore be integrated into the survivorship model rather than treated as optional extras.

Emotional recovery should be recognized as an important component of physical recovery.

8. SEXUAL, HORMONAL & INTIMATE HEALTH

Cancer and cancer treatment can affect menopause, testosterone, fertility, body image, pelvic health, sexual function and intimate relationships. These subjects are frequently under-addressed despite their importance to quality of life.

Survivorship care should provide an appropriate pathway for discussing these issues openly and obtaining specialized clinical support when needed. Quality of life includes the ability to reconnect with one's body, relationships and sense of identity following cancer.

9. COGNITIVE HEALTH — “CHEMO BRAIN” AND BEYOND

Problems with concentration, memory, processing speed and mental fatigue can interfere with work, relationships and everyday life. Survivors experiencing cognitive changes can be offered assessment, education, compensatory strategies, cognitive rehabilitation where appropriate, exercise and sleep interventions, and referral for further evaluation when necessary.

The objective is to help survivors regain confidence in their cognitive abilities and provide practical strategies for managing persistent difficulties.

10. RETURNING TO WORK, FAMILY & EVERYDAY LIFE

Perhaps the most important part of survivorship is not clinical at all. It is helping someone become a person again—not simply a patient. Returning to work. Traveling. Exercising. Rebuilding relationships. Reestablishing routines. Regaining confidence. Developing new goals. Managing fear without allowing fear to dominate everyday life.

Some survivors may also need vocational support, workplace accommodations, financial navigation, caregiver and family support or assistance adapting to a changed physical capacity.

This is where quality of life becomes a meaningful objective of cancer care.

AN INDIVIDUAL SURVIVORSHIP HEALTH PLAN

Every participant should ultimately leave with an Individual Survivorship Health Plan—a living roadmap developed around the individual's cancer history, treatment exposures, present health, functional needs and personal goals.

The plan may incorporate:

Exercise and physical activity recommendations
Nutritional priorities
Rehabilitation needs
Cancer surveillance and recommended medical follow-up
Cardiovascular and metabolic considerations
Bone-health considerations
Lymphedema and neuropathy management
Sleep and fatigue strategies
Cognitive-health support
Emotional and behavioral-health resources
Sexual and hormonal health considerations
Healthy weight and body-composition goals where appropriate
Tobacco and alcohol risk reduction
Social, family and caregiver support
Return-to-work and functional goals
Personal quality-of-life objectives

Progress can then be reassessed at defined intervals—for example, at baseline, 90 days, six months and one year. This transforms survivorship from a vague instruction to “take care of yourself” into an organized program of recovery and long-term health management.

A MULTIDISCIPLINARY SURVIVORSHIP TEAM

Cancer recovery cannot realistically be addressed by one professional discipline.

A comprehensive survivorship program can bring together oncology, primary care, exercise oncology, physical therapy, nutrition, behavioral health, rehabilitation, lymphedema specialists, sexual-health professionals and other specialists according to the needs of the individual.

The oncologist does not need to become the patient's nutritionist, exercise physiologist or rehabilitation therapist. Instead, the program creates a coordinated pathway connecting survivors with the right expertise at the right stage of recovery.

MEASURING MORE THAN SURVIVAL

Cancer programs understandably measure survival, disease progression, recurrence and treatment response.

A survivorship program should measure something additional: How well is the survivor living?

Depending upon the program and clinical setting, outcomes may include changes in strength, cardiovascular fitness, mobility, fatigue, sleep, body composition, functional capacity, emotional well-being, return to work, adherence to physical activity and overall quality of life.

These measurements can demonstrate that survivorship is not merely a philosophy. It can become a structured and measurable component of cancer care.

THE GREATER VISION: SURVIVORSHIP IS A PHASE OF CARE

The larger opportunity is to redefine what society means by a cancer survivor. Survivorship should not merely mean that treatment stopped. It should mean that another phase of care has begun. Staying Active During Cancer Treatment helps individuals preserve as much physical and emotional capacity as medically appropriate while undergoing treatment.

Post-Treatment Cancer Recovery helps individuals rebuild that capacity afterward. Together, these pathways create a continuum extending from diagnosis and active treatment through rehabilitation, survivorship, prevention-focused health management and healthy aging.

The program does not promise that exercise, nutrition or lifestyle will prevent cancer from returning. Instead, it gives survivors something equally important: evidence-informed ways to participate actively in their own recovery, address modifiable risks, rebuild physical reserve and improve the quality of the life they fought so hard to preserve.

Cancer treatment has traditionally centered on an essential question: “How do we treat this cancer?”

A comprehensive survivorship program adds another: “How do we help this person live as well as possible during treatment—and how do we help them become healthy, strong and active afterward?”

That is the mission of the Cancer Survivorship & Recovery Program. The objective is not simply surviving cancer. It is helping people live well during treatment, recover after treatment, protect their future health and reclaim the fullest quality of life possible.

Report Credit

This report is brought to you by the Institute for Progressive Health Sciences, in collaboration with BeMore Advisory™, the National Cancer Collective, and the Male Breast Cancer Global Alliance. Together, these organizations support progressive health education, cancer advocacy, survivorship, professional collaboration, and whole-person approaches to improving quality of life during and after cancer treatment.

Thursday, March 19, 2026

Spotlight on Exercise Oncology

Redefining Cancer Care through Exercise Oncology

In today’s rapidly evolving healthcare landscape, innovation is no longer confined to pharmaceuticals, surgical techniques, or diagnostic breakthroughs. Increasingly, a powerful yet often underutilized tool is gaining recognition within oncology: exercise as medicine. At the forefront of this movement is Christopher Fitzmaurice, MS, CEP, CSCS, CET, a clinical exercise physiologist at the University of Miami Health System whose work is helping reshape how cancer patients and survivors approach recovery, resilience, and long-term health.

With credentials that span clinical exercise physiology, strength and conditioning, and cancer-specific training, Fitzmaurice represents a new generation of healthcare professionals bridging performance science with medical care. As a Certified Cancer Exercise Trainer (CET) and Certified Strength & Conditioning Specialist (CSCS), his expertise lies not only in optimizing physical performance, but in translating that knowledge into meaningful, life-enhancing outcomes for individuals navigating one of the most challenging diagnoses imaginable.

From Clinical Practice to Purpose-Driven Mission

Currently working within the executive health and concierge medicine program at the University of Miami, Fitzmaurice’s journey was shaped by his earlier tenure at the Sylvester Comprehensive Cancer Center, where he spent several years working directly with cancer patients and survivors. It was here that his professional path evolved into a mission.

“My mission is to make exercise the standard of care—not just for some, but for all, and especially for cancer survivors.” While many practitioners enter oncology through traditional clinical routes, Fitzmaurice’s perspective was informed by both personal and professional experiences. Having lost family members to cancer, he carried a personal connection to the disease. However, it was his hands-on clinical exposure that crystallized his purpose.

“I’ve always been connected to cancer through family, but I didn’t become truly passionate until I started working directly with patients and saw the need firsthand.”

Exercise Oncology: From Concept to Clinical Reality

Exercise oncology has undergone a remarkable transformation over the past decade. Once viewed as supplementary or optional, it is now supported by a growing body of evidence demonstrating its clinical value. Fitzmaurice has been both a witness to and a contributor within this expanding field. “We’ve seen an explosion in randomized clinical trials—nearly a 300% increase—showing how exercise can dramatically impact cancer survivors.”

These studies have revealed that structured exercise can reduce treatment-related side effects, improve cardiovascular and muscular function, enhance mental well-being, and support overall quality of life. More importantly, exercise is now being examined not just as recovery, but as a therapeutic intervention throughout the cancer journey.

Beyond Rehabilitation: A Continuum of Care

Historically, physical rehabilitation in oncology was largely reactive—focused on helping patients recover from surgery or treatment-related impairments. Fitzmaurice is part of a growing movement that challenges this limited framework. “Exercise is no longer just something we think about after treatment. We now understand its value during treatment and even before it—what we call prehabilitation.”

This shift introduces a continuum of care: exercise before treatment to build resilience, during treatment to maintain function, and after treatment to support recovery and long-term health. “Rehabilitation helps treat the burden of disease, but exercise helps maintain function and improve outcomes over time.”

During the COVID-19 pandemic, Fitzmaurice expanded this model through telehealth, delivering both individual and group-based exercise programs to patients who were otherwise isolated from care. “The impact wasn’t just physical—it was mental as well. You could see how much it meant for patients to stay active and engaged.”

Advocacy and Addressing Hidden Challenges

Courtesy of: Scott Baker

Beyond clinical application, Fitzmaurice is also an advocate—particularly in areas where stigma or lack of awareness can hinder care. One such area is male breast cancer, a condition often overlooked or underreported. Through his work with cancer survivors, he has observed how denial and social perceptions can delay diagnosis and treatment. “The most important thing is not to be in denial. When people avoid acknowledging a diagnosis, they miss the opportunity to access the care and support that could help them.”

He emphasizes that survivorship programs and supportive care models must be inclusive and accessible to all patients. “We need to create a space where everyone feels included—especially men—because the rates are rising, and the need is real.”

Collaboration and Leadership in a Growing Field

Fitzmaurice’s work is strengthened by his collaborations with leading voices in oncology and exercise science, including Dr. Jay Harness, a former oncologic surgeon who has become a strong advocate for exercise-based interventions in cancer care.

Their partnership reflects a powerful convergence of clinical oncology and performance science. “When I learned about Dr. Harness’s history—over 30 years as an oncologist—and his commitment to exercise oncology, it opened my eyes to how impactful this field can be.” Together, they are contributing to publications and initiatives aimed at advancing exercise as a recognized and standardized component of cancer care.

The Future: Research, Education, and Systemic Change

Looking ahead, Fitzmaurice is committed to further advancing the field through research and education. He plans to pursue a PhD with a focus on exercise oncology, with the goal of strengthening the scientific foundation that supports its integration into clinical practice. “I want to help build the evidence that ensures cancer survivors receive the level of care they deserve—and that practitioners know how to implement exercise properly.”

His long-term vision is clear: to influence healthcare systems, inform clinical guidelines, and ensure that exercise is no longer considered optional, but essential.

A New Standard in Cancer Care

Christopher Fitzmaurice embodies a shift in modern medicine—one that prioritizes proactive, integrative, and patient-centered care. With a unique blend of clinical expertise and human insight, he is helping to redefine the role of movement in oncology.

In his model, exercise is not an afterthought. It is a strategy. A therapy. A lifeline. As research continues to validate what practitioners like Fitzmaurice have long understood, the future of cancer care will increasingly embrace this approach—where healing is not only delivered through treatment, but cultivated through movement, strength, and resilience.

And in that future, exercise will not simply support recovery—it will help define it.

Aftermath

On Exercise as a Clinical Ally in Cancer Recovery

By Robert L. Bard, MD, DABR, FAIUM, FASLMS

As a diagnostic imaging specialist, my role has always centered on identifying disease—locating it, defining it, and understanding its behavior. But over the years, one of the most important realizations in oncology has been this: detection is only the beginning. What follows—how the body responds, heals, and adapts—defines the patient’s true outcome.

In this context, exercise has emerged as one of the most valuable yet historically underutilized tools in cancer care.

From a clinical standpoint, cancer and its treatments impose a profound physiological burden. Chemotherapy, radiation, and surgical interventions often leave patients with decreased muscle mass, impaired circulation, chronic inflammation, and significant fatigue. These are not secondary issues—they directly influence recovery, resilience, and long-term survival.

What professionals like Christopher Fitzmaurice are advancing through exercise oncology is a critical shift in how we approach this recovery phase. Exercise is not simply about fitness. It is about restoring function at a cellular and systemic level.

We now understand that structured physical activity improves vascular circulation, enhances oxygen delivery, and supports lymphatic flow—key mechanisms that help the body clear metabolic waste and reduce inflammatory burden. From an imaging perspective, we often correlate improved blood flow with better tissue health and recovery potential. Movement, quite literally, fuels healing.

Equally important is the role of exercise in preserving muscle integrity and metabolic stability. Loss of strength is one of the most overlooked consequences of cancer treatment, yet it is directly tied to a patient’s independence and long-term prognosis. Rebuilding that strength is not cosmetic—it is foundational to survival.

There is also a neurological component that cannot be ignored. Physical activity stimulates neurochemical pathways associated with mood, cognition, and resilience. Patients who engage in structured exercise programs frequently demonstrate improved mental clarity and emotional stability—factors that are essential when navigating the psychological weight of a cancer diagnosis.

From a rehabilitation standpoint, exercise bridges the gap between treatment and true recovery. Traditional rehab often addresses isolated impairments, but exercise provides a global, integrative benefit—supporting cardiovascular, musculoskeletal, and neurological systems simultaneously.

Most importantly, exercise introduces agency back into the patient experience. Cancer treatment can often feel passive—patients receive therapies, undergo procedures, and wait for results. Exercise shifts that dynamic. It gives patients an active role in their own recovery, reinforcing both physical capability and psychological empowerment.

As we look toward the future of oncology, it is clear that multidisciplinary collaboration will define the highest standard of care. Imaging, medical treatment, rehabilitation, and performance science must work together—not in silos, but as an integrated system.

Exercise oncology is not an alternative concept. It is a necessary evolution.

Reprise: Exclusive from HealthTech Reporter

ReBuilding to Last: Strength, Longevity, and the Technology That Multiplies Human Potential

An exclusive interivew with ELLEN TYSON

Written by: Lennard M. Goetze, Ed.D

ELLEN TYSON does not frame fitness as vanity. She frames it as survival, agency, and long-term independence. A strength training coach and Visionbody brand evangelist, Tyson speaks with the authority of lived experience: the arc of her life reshaped by movement after decades of chemical depression, and later refined by a clear-eyed understanding of what aging demands of the body. Her message is simple but uncompromising: muscle is the infrastructure of longevity. “Muscle is your biggest organ of longevity,” Tyson says. “Before supplements, before vitamins—build your muscles.” For Ellen, strength training is not a trend. It is preventive medicine.

FROM SURVIVAL TO STRENGTH: A PERSONAL TURNING POINT

Tyson’s path into strength training was not born of aesthetics or athletic ambition. For much of her adult life, she managed recurring chemical depression. In her forties, she discovered that consistent exercise did something medication never fully achieved: it stabilized her mental health. “Since I was 44… I have not had a depressive episode,” she explains. “I’ve been sad, but not the chemical depression that sent me over the edge every couple of years.”

What began as a social activity became a physiological reset. Over time, she recognized a deeper pattern: movement changed not only her mood, but her metabolism, bone density, and resilience. This realization reframed fitness from self-improvement to self-preservation. “Resistance training is preventative medicine,” she says.

As her children grew older, Tyson transitioned into professional training. The work resonated because it mirrored her own transformation. She no longer trained clients for appearance. “I care not what I look like in a bikini… I care about being strong and healthy. The byproduct is the lean body.”

The outcome is functional longevity: the ability to walk well, recover faster, and remain metabolically active with age.

STRENGTH AS THE SPINE OF LONGEVITY

Tyson’s philosophy rests on a clinical truth increasingly supported by research: skeletal muscle is a metabolic organ that influences glucose control, immune competence, hormonal balance, and bone density. As muscle declines with age (sarcopenia), risk rises for falls, insulin resistance, and frailty. Tyson compresses this science into lived wisdom: “Once your muscles go, your immune system goes down, your bone density goes down—everything goes.”

For postmenopausal women, the stakes are higher. Hormonal shifts favor visceral fat gain, accelerate bone loss, and slow recovery. Tyson frames muscle as the first line of defense. “For postmenopausal women… the first line of defense always is muscle.”

Her guidance is not punitive. It is practical: build the engine that supports every other system. She also confronts the most common barrier—time. “If you don’t take time for your wellness, you will be forced to take time for your illness.”

In this framing, exercise is not an added burden; it is a protective investment against the future cost of disease.

VISIONBODY: WHEN TECHNOLOGY MULTIPLIES EFFORT

Tyson’s role as a Visionbody brand evangelist grew out of years of experience with electro-muscle stimulation (EMS). Visionbody’s wireless suit delivers
low to mid frequency electrical stimulation to contract muscles deeply during movement, amplifying conventional training. The suit engages most major muscle groups in short sessions, turning 20 minutes into a comprehensive workout.

What differentiates Visionbody in Tyson’s account is depth and comfort. She contrasts higher-frequency stimulation with older EMS systems that sting and work superficially. The Visionbody platform, she explains, reaches deeper muscle layers, increasing oxygen demand and circulation. “It engages, activates your muscles deep and hard—more than you can on your own.”

This physiological load accelerates adaptation while preserving joint safety. For busy professionals and older adults, efficiency matters. “It’s a 20-minute workout. It maximizes your time.” Tyson notes.

In her practice, the suit does not replace training—it sharpens it. She still coaches form, balance, and progressive loading. Technology becomes a multiplier, not a shortcut. The platform’s clinical applications extend beyond fitness. Tyson describes medical protocols for individuals with limited mobility—patients in wheelchairs, neurological conditions, or prolonged bed rest—where stimulation can help maintain circulation and reduce muscle atrophy.

This dual-use design—performance and rehabilitation—reflects her broader belief that wellness tools should scale across health states, not only serve the already fit.

STRENGTH AS REHABILITATION, NOT JUST PERFORMANCE

In conversations with clinicians, Tyson emphasizes how muscle preservation intersects with recovery from illness and cancer treatment. She references Visionbody’s origins in survivorship and rebuilding after severe muscle loss. Increased circulation and oxygenation, she notes, support cellular recovery.

While not a medical cure, strength training—augmented by EMS—becomes a rehabilitative bridge back to autonomy. Her coaching style remains cautious with vulnerable populations. Stimulation intensity is titrated; progression is gradual. “Too much of a good thing… you can actually deteriorate muscles if you go too strong.” The principle mirrors her longevity ethic: sustainable gains beat dramatic but brittle progress.

THE EDUCATOR’S ETHIC: TEACHING AGENCY

Tyson’s influence is not confined to training sessions. She identifies as an educator, translating physiology into habits people can sustain. Her most repeated lesson is behavioral: the hardest part is showing up. “The hardest part about working out is actually getting to the gym. Once you’re there, you’re motivated.”

This framing lowers the psychological barrier to action and builds consistency—the real driver of results. Her messaging to midlife women is resolute and hopeful. “It’s never too late to build muscles.” She positions strength as a reclaiming of agency during hormonal transitions often framed as decline. In doing so, she reframes longevity as something practiced daily, not postponed to later interventions.

WHY ELLEN TYSON RESONATES

Tyson’s authority is not performative. It emerges from congruence: she practices what she teaches. Her body becomes evidence, but her story carries the proof. She connects mental health, metabolic health, and musculoskeletal resilience into a single narrative of self-stewardship. Technology fits into this arc not as spectacle, but as a pragmatic amplifier of effort. “I don’t understand people who wait until they’re sick to take care of their health,” she says.

In her framework, the body is not a machine to fix when broken; it is an ecosystem to support while it’s working.

THE TAKEAWAY

Ellen Tyson’s message to the longevity movement is blunt and humane: build muscle to protect your future self. Pair disciplined training with smart tools like Visionbody when appropriate. Treat strength as infrastructure—for balance, immunity, bone density, recovery, and mental health. And begin now, not later. Her ethic closes the loop between effort and technology, prevention and performance, body and agency. Strength training, in her view, is not about aesthetics, but actually being powerful from the inside an out. It is about staying capable—long enough to keep living well, longer.

WHERE ENERGY MEETS EVIDENCE: Imaging the Physiology Of Strength And Recovery

This February, Ellen Tyson of Visionbody and Dr. Robert Bard will collaborate on a focused performance review and medical validation initiative examining the clinical impact of Visionbody’s EMS muscle-strengthening technology. The project is designed to move beyond anecdotal claims by applying objective diagnostic imaging and monitoring protocols to evaluate measurable physiological change.

Dr. Bard’s interest centers on imaging-guided assessment of EMS-driven energy induction and its real-world effects on neuromuscular activation, muscle strength development, tissue response, and functional regeneration. Of particular interest is how EMS may influence neuromuscular signaling pathways associated with neurotransmitter activity and recovery mechanisms—areas that are increasingly relevant to aging populations, rehabilitation, metabolic dysfunction, and post-treatment recovery.

Throughout February, performance data will be documented through serial monitoring and imaging-based observation to identify patterns of response, adaptation, and potential therapeutic relevance. This initiative reflects a growing demand for evidence-based validation of non-invasive technologies entering the clinical and wellness landscape.

Findings and clinical observations from this collaboration will be published exclusively in HealthTechReporter.com, offering clinicians, researchers, and informed patients a transparent look at how emerging EMS technologies perform under real diagnostic scrutiny.

(Complete feature coming soon)

Copyright Notice © 2025 Overture Publications. All rights reserved. This work and all materials contained herein are the intellectual property of Overture Publications under the Institute for Global Health Innovations and its authorized contributors. No part of this manuscript may be reproduced, stored in a retrieval system, transmitted in any form or by any means—electronic, mechanical, photocopying, recording, or otherwise—without prior written permission from the publisher. All names, images, and materials are protected under applicable copyright and intellectual-property laws in the United States and internationally. Any reference to individuals, institutions, or proprietary entities is for informational purposes only and does not imply endorsement or affiliation unless expressly stated. All trademarks and service marks mentioned are the property of their respective owners.

If our goal is not only to extend life but to improve the quality and strength of that life, then exercise must be recognized as a central pillar in cancer recovery, rehabilitation, and ultimately, longevity.

Tuesday, May 13, 2025

Pennsylvania's HB433 Advances: A Landmark Bill for Breast Health Equity Unanimously Passes the House

By Lennard M. Goetze, Ed.D – AngioMedical News

In a significant step toward improving breast health care equity in Pennsylvania, House Bill 433 (HB433) passed the Pennsylvania House of Representatives with a resounding 198-5 vote on May 12, 2025. This pivotal legislation, aimed at expanding insurance coverage for diagnostic breast examinations without cost-sharing barriers, represents a victory for patients, advocates, and healthcare providers alike.

Background: The Need for HB433

The origins of HB433 trace back more than a year, when Cheri Ambrose, Founder and President of the Male Breast Cancer Global Alliance, reached out to the Pennsylvania Governor’s office and legislative stakeholders to advocate for improved access to breast imaging services — not just for women, but for all individuals, including men diagnosed with or at risk for breast cancer.

Historically, state insurance mandates have focused on screening mammograms, often leaving significant gaps in coverage for diagnostic follow-ups like MRIs, ultrasounds, and diagnostic mammograms when abnormalities are detected. This has led to financial strain and delayed diagnoses for many patients, particularly men with breast cancer, a group frequently overlooked in traditional breast health policy.

Recognizing this, the House Democratic Insurance Committee began work on HB433, designed to ensure that both screening and diagnostic breast imaging would be accessible without burdensome out-of-pocket costs — a move aligned with updated guidelines from the U.S. Health Resources & Services Administration (HRSA) and federal health insurance mandates set to take effect in 2026.

The Legislative Process: Stakeholder Collaboration and Amendment

On March 26, 2025, Joseph Keller, Senior Research Analyst for the House Democratic Insurance Committee, formally reached out to stakeholders for feedback on both the bill and a proposed amendment (A00204). This amendment refined HB433’s language to enhance its inclusivity and legal precision. Key changes included:

• Replacing gendered language: Substituting “women” with “individuals” to ensure breast health coverage for all, regardless of gender.

• Clarifying insurance applicability: Modernizing outdated legal references and definitions within Pennsylvania’s mammogram law.

• Defining covered costs: Clearly stating that “all costs” would include copayments, coinsurance, and deductibles — with exceptions for certain high-deductible health plans tied to Health Savings Accounts.

• Aligning with HRSA guidelines: Ensuring diagnostic breast examinations would include MRIs, ultrasounds, or diagnostic mammograms for any suspected abnormalities detected in initial screenings.

Cheri Ambrose remained an engaged advocate throughout the process, communicating regularly with Keller and other House staff to monitor progress. After a successful committee adoption of the amendment in April 2025, the bill was scheduled for a final House vote in May.

Final Passage and What Comes Next

On May 12, 2025, the Pennsylvania House of Representatives Led by House Speaker Rep. Joanna McClinton amended the historical act of May 17, 1921 (P.L.0682, No.0284), known as the "Insurance Company Law Of 1921. The house voted overwhelmingly in favor of HB433. Cheri Ambrose received confirmation of the vote directly from Joseph Keller, who expressed appreciation for the ongoing advocacy and stakeholder input that helped shape the bill’s passage. The bill now moves to the Pennsylvania Senate for further consideration. If approved there, it will proceed to the Governor’s desk for final enactment. “No one should have to go into debt to access the health care they need, but high out-of-pocket costs can discourage people from seeking care", states Rep. McClinton. By passing HB 433 this week, the state House took action to help more Pennsylvania men and women access diagnostic breast imaging which can save lives and reduce the overall costs to our state’s healthcare system.”

(L-Image) Representative Gina H. Curry - PA General Assembly also shared her statement about the recent historical legislative amendment. “Breast cancer does not discriminate, and neither should access to care. Men get breast cancer too, fathers, brothers, sons, yet many delay care due to stigma or cost. HB 433 ensures that if you find a lump, you can get answers no matter your gender, zip code, or bank account. Black and Hispanic women are more likely to be diagnosed at later stages and have higher mortality rates. Black women are 2.7 times more likely to face triple negative breast cancer and 28 percent more likely to die from it. This bill tears down the financial walls that keep people from getting the diagnostic tests they need. We are not just saving women’s lives, we are saving lives, period. Because cancer does not wait, and neither should we."

What This Means for the Public

For the public — particularly those affected by or at risk for breast cancer — HB433 represents a monumental step forward. Should it become law, Pennsylvanians will no longer face the burden of out-of-pocket costs for essential diagnostic breast exams if abnormalities are detected during initial screenings. This legislation ensures insurance plans offered, issued, or renewed in the Commonwealth will cover these vital services, aligning state law with evolving federal preventive care standards.

Importantly, by adopting gender-neutral language and including men within the framework of breast health care policy, HB433 acknowledges the realities faced by male breast cancer patients, a demographic long overshadowed in public health conversations.

Conclusion

HB433’s progress exemplifies the power of advocacy, stakeholder collaboration, and responsive legislation. As Pennsylvania moves one step closer to codifying these protections into law, advocates like Cheri Ambrose and legislative champions within the House Insurance Committee offer a clear reminder of what dedicated, patient-centered policy work can accomplish.

For more information on male breast cancer and ongoing advocacy initiatives, visit the Male Breast Cancer Global Alliance.